Peptide library › Infections
Echinocandins
Also known as Caspofungin, Micafungin, Anidulafungin, Rezafungin, Cancidas, Mycamine, Eraxis, Rezzayo
Family of hospital antifungal drugs for serious yeast and mould infections.
What people use it for
- Candida bloodstream and deep infections
- Oesophageal thrush
- Preventing fungal infections in some transplant patients
What Echinocandins does in the body
Lipopeptides that block an enzyme fungi need to build their cell walls. Human cells don't have cell walls, so they're well tolerated.
Strength of evidence
Strong: first-line treatment for invasive candida infections.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Infusion reactions
- Raised liver enzymes
- Fever and phlebitis
Who should avoid it or take extra care
- Known allergy to echinocandins
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved: caspofungin (2001), micafungin (2005), anidulafungin (2006) and rezafungin (2023). Hospital use.
How it's taken
Route: Drip into a vein; daily, or weekly for rezafungin
How long it lasts (half-life): About 9 to 26 hours for most; about 5 days for rezafungin
Storage
Stored and prepared by the pharmacy or clinic, following the product label.
Latest research & news
- Candida auris colonization or infection in the ear of four patients with chronic otitis externa: A case series and literature review
Research · Review · PubMed · Curr Med Mycol · 21 Nov 2026 - Evaluation of an antifungal stewardship program in a tertiary-care hospital: Analysis of antifungal consumption and targeted interventions
Research · Study · PubMed · Farm Hosp · 20 Nov 2026 - A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
Clinical trial · Recruiting · Phase 3 · Updated · ClinicalTrials.gov · 19 Nov 2026 - A synthetic cationic thiopyrylium compound exploits preferential phosphatidylserine recognition to exert antifungal activity
Research · Study · PubMed · Bioorg Chem · 15 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Echinocandins privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Echinocandins in Fiala How to installMore in Infections
- BacitracinPeptide antibiotic in over-the-counter ointments for minor cuts and grazes.
- Dalbavancin, oritavancin and telavancinLong-acting hospital antibiotics related to vancomycin, used for serious skin infections including MRSA.
- DaptomycinHospital antibiotic for serious skin and bloodstream infections, including MRSA.
- Polymyxin B and colistinOld peptide antibiotics now kept as a last resort for multidrug-resistant gram-negative infections.
- VancomycinLong-established hospital antibiotic for MRSA and other serious infections; taken by mouth for C. difficile.
- EnfuvirtideFirst HIV fusion inhibitor, a twice-daily injection for resistant HIV; discontinued in the US in 2025.
- MurepavadinExperimental antibiotic designed to target Pseudomonas, the main lung infection in cystic fibrosis.
- BrilacidinExperimental drug that mimics the body's own antimicrobial defensins, studied for infections and inflammation.